EuroEyes International Eye Clinic Limited

HKEX:1846.HK

4.25 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q1
Revenue 184.186184.186183.954183.954346.382173.191294.665147.333315.626157.813313.253156.627319.678159.839284.985142.493188.83394.417111.759111.759104.86101.31599.634
Cost of Revenue 110.18110.1899.98499.984185.8789.4173.21383.188180.22986.536166.59580.267166.91579.927146.50573.253113.21356.60768.99268.99261.10355.60458.509
Gross Profit 74.00774.00783.9783.97160.51283.791121.45264.145135.39771.277146.65876.36152.76379.913138.4869.2475.6237.8142.76742.76743.75645.71241.126
Gross Profit Ratio 0.4020.4020.4560.4560.4630.4840.4120.4350.4290.4520.4680.4880.4780.50.4860.4860.40.40.3830.3830.4170.4510.413
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 24.36124.36125.39925.39919.25319.25318.17818.17820.49720.49715.67915.67918.8118.8117.04417.04413.20213.20222.93522.9359.4718.5142.294
Selling & Marketing Expenses 18.17618.17619.15819.15817.30117.30113.76413.76414.56714.56713.52713.52713.35713.35711.87711.87711.14511.14517.31817.31814.35911.21411.092
SG&A 42.54542.54544.63844.63866.03736.58360.00131.95960.84735.06352.34929.26157.27232.16757.84128.9348.69424.35240.25340.25323.82929.72813.386
Other Expenses -1.409-1.409-7.458000000000000000006.1145.062.158
Operating Expenses 41.13641.13637.18138.33766.03738.93360.00133.53860.84734.40552.34924.66557.27230.09557.84131.53448.69423.94941.93341.93329.94234.78915.544
Operating Income 32.87132.87146.78941.74294.47547.22961.45133.53174.5536.84394.30947.85595.49147.92380.63941.53426.92613.5713.60613.60613.60210.98524.933
Operating Income Ratio 0.1780.1780.2540.2270.2730.2730.2090.2280.2360.2330.3010.3060.2990.30.2830.2910.1430.1440.1220.1220.130.1080.25
Total Other Income Expenses Net 2.3522.3522.2142.214-1.871-3.666-2.737-0.662-4.284-1.2525.3872.6780.4860.066-8.113-5.271-0.804-0.723-2.694-2.694-3.061-0.652-1.626
Income Before Tax 35.22235.22249.00349.00392.60446.30258.71429.35770.26635.13399.69649.84895.97747.98972.52636.26326.12213.0610.2250.22510.54110.33323.307
Income Before Tax Ratio 0.1910.1910.2660.2660.2670.2670.1990.1990.2230.2230.3180.3180.30.30.2540.2540.1380.1380.0020.0020.1010.1020.234
Income Tax Expense 12.06812.06816.43216.43224.49312.24718.6639.33226.79913.432.8916.44530.39915.225.13212.5669.4434.7224.7484.7488.1017.41410.124
Net Income 22.07722.07731.88331.88367.47633.73842.94421.47246.52823.26468.42234.21165.13832.56947.41323.70718.1679.084-4.311-4.3112.2642.91813.183
Net Income Ratio 0.120.120.1730.1730.1950.1950.1460.1460.1470.1470.2180.2180.2040.2040.1660.1660.0960.096-0.039-0.0390.0220.0290.132
EPS 0.0670.0670.0960.0960.20.10.130.0650.140.070.210.10.20.0990.140.0560.0550.028-0.016-0.0160.0070.0090.042
EPS Diluted 0.0670.0670.0960.0960.20.10.130.0650.140.070.210.10.20.0990.120.0560.0550.028-0.016-0.0160.0070.0090.042
EBITDA 43.2443.2451.35951.359140.2156.199102.85341.543117.58745.727141.755.02137.09655.018111.01147.92962.61119.60919.08319.08313.3328.31839.77
EBITDA Ratio 0.2350.2350.2790.2790.3930.3240.3410.2820.3690.290.4220.3510.4140.3440.4040.3360.3160.2080.1710.1710.1290.2790.406